论文部分内容阅读
最近中国开发的新产品如下: *据人民日报报道,一种用于冠心病的新药—心宝丸(Xin-bao-wan),目前正在北京中药厂生产。 *据中国医药报报道,珠海经济特区的丽珠制药厂最近开始生产治疗胃溃疡的Le-wei片剂,该药与施贵宝公司的Roetr片剂一次硝酸铋相似。以前,中国每年进口Ro—er片30亿片以上,现在丽珠制药厂每年生产该药20亿片。其余部分将用国内设备生产。 *据中国医药报报道,抗真菌药物一环吡酮胺(Ciclopirox olamine)已被中国当局认可,该药是湖北省医药工业研究所开发的。 *据中国制药报报道,一种增强免疫力
Recently, the new products developed in China are as follows: * Xin-bao-wan, a new drug for coronary heart disease, is currently being manufactured in Beijing Chinese medicine factory, according to the People’s Daily. * According to the China Medical Daily, the Zhuhai Special Economic Zone’s Livzon Pharmaceutical Factory recently started manufacturing Le-wei tablets for stomach ulcers similar to the primary bismuth nitrate found on the Squibb Roetr tablets. In the past, China imported over 3 billion Ro-er tablets annually, and now Lvzhu Pharmaceuticals produces 2 billion tablets a year. The rest will be produced using domestic equipment. * Ciclopirox olamine, an antifungal drug, has been approved by the Chinese authorities, according to the China Medical Daily, developed by Hubei Institute of Pharmaceutical Industry. * According to China National Pharmaceutical News reported that a kind of enhance immunity